Skip to primary content
Skip to secondary content

Didymus Judas Thomas' Hipocritical Oath Blog

Stanislaw Rajmund Burzynski, Stanislaw R. Burzynski, Stanislaw Burzynski, Stan R. Burzynski, Stan Burzynski, S. R. BURZYNSKI, S. Burzynski, Arthur Burzynski, Hippocrates Hypocrite Hypocrites Critic Critics Critical HipoCritical

Didymus Judas Thomas' Hipocritical Oath Blog

Main menu

  • Home
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • .
  • 1
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 1998 (1/15/1998)
  • 1999 (2/1999) Volume 74 Number 2 pg. 137 – 3 pgs.
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • About
  • List of Articles

Tag Archives: “http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q1-2012-US-dollar-translation.pdf”

OUCHIE !!!

Posted on December 2, 2013 by didymusjudasthomas
Reply

20131202-002825.jpg
Bob ‘n Weave Blaskiewicz selected from his
select “Sexual Predator” syllabus he must cite from; during sessions like his series at the University of Wisconsin-Eau Claire, where he surely must supply sorry examples of how to supposedly elicit a “Pavlov’s dog” style series of events from confused children; who’ve been told to “not talk to strangers,” and “never go anywhere with someone you don’t know,” when he Gabroni’s this gem and juice:
——————————————————————
“He IS big pharma” [1]
——————————————————————
How quaint

Bob is unable to back-up his biased talking-head brillnuance

But he hopes mightily that his brilliance of adding the nut menagerie symbolism of menutgerie:
——————————————————————
“He uses the same legal loopholes available to drug companies … “ [2]
——————————————————————
Basically, “The Skeptics™,” according to Bob, believe that every law they disagree with is a “legal loophole,” but every law they might not agree with, but which their opposition feels is a “legal loophole,” is a valid law to them

But I digress

Bob would have you believe that he thinks his readers are NOT smarter than a fifth-grader; and perhaps that belief is well founded, because a lot of Bob’s regular followers may not really be: smarter than a 5tłh-grader”, based on his theory that if a child were instructed to never go somewhere with a stranger, Bob believes that children, like his readers, can be “suckered” into ignoring warnings, and instead, if they are told a “plausible story” like:
——————————————————————
“Your parent needs your help and they want you to follow me”

“They have some candy for you”
——————————————————————
they will forego that which they have been told is the intelligent, correct choice, for the big, shiny, fruit of the stupid stick tree
——————————————————————
Now, let’s review Blatherskitewicz’s attempt at Tolstory:
——————————————————————
“He IS big pharma”: “He uses the same legal loopholes available to drug companies … “
——————————————————————
A 5th-grader is smart enough to see through Bobby’s piss-poor Pulitzer Prize phallicy

Bobby excreted end-run attempt around intelligent-design, is his word-salad salute to
“Stupid is, as Stupid Does”

He tries to MisDisInform, by depositing that because Burzynski has to use the same, as he puts it, “legal loopholes” as BILLION Pharma, that this somehow translates into Burzynski being Big Pharma

Jeepers, creepers, this would be akin to me attempting to pull a Pol Pot over your Peepers, by trying to claim that just because Bobby Blatherskitewicz sits down and uses the same type of device; a toilet, to attempt to rid himself of what he is obviously “full of,” that this means he is smarter than a 5th-grader who uses the same device, when it is clear that even medical-grade cannabis couldn’t help Bobby Blatherskite be smarter than a 5th-grader
——————————————————————
“He IS big pharma”: “He uses the same large poophole“, and even the largest roll of Charmin in the world wouldn’t help him
——————————————————————
Since Booby couldn’t name an actual Big pharmaceutical company to contrast Burzynski with, let’s take a look at one, shall we ?
——————————————————————
2/7/2012, Monday, GlaxoSmithKline LLC (GSK) was fined $3 BILLION ($3,000,000,000 Billion) dollars, for actions which occurred from
(4/1998 – 2007)

How did this $3 BILLION dollar slap on the wrist affect GSK ?
——————————————————————
Well, I’m glad you asked !
——————————————————————
Before “Black Monday”, 2/7/2012, EARNINGS PER SHARE was:

40.6¢ – .12/31/2011 (3 months ended)

Afterwards, a 1.6¢ rise:

42.2¢ – 3/31/2012 (3 months ended)
——————————————————————
Before the United States Department of Justice’s devastating news, Profit attributable to shareholders was:

$2,017,000,000 BILLION – .12/31/2011 (3 months ended)

After, a $77 MILLION ($77,000,000 Million) dollar rise to:

$2,094,000,000 BILLION – 3/31/2012 (3 months ended)
——————————————————————
Before the 2/7/2012 surprise, Cash and cash equivalents (Current assets) was:

$8,857,000,000 BILLION – .12/31/2011 (3 months ended)

Afterward, a $161 MILLION ($161,000,000 Million) rise to:

$9,018,000,000 BILLION – 3/31/2012 (3 months ended)
——————————————————————
Before the announcement, Total current assets:

$25,059,000,000 BILLION – .12/31/2011 (3 months ended)

After the FALL, a $986 MILLION ($986,000,000 Million RISE to:

$26,045,000,000 BILLION – 3/31/2012 (3 months ended)
——————————————————————
And, last, but certainly NOT in any way, shape, or form, least, before “that” day, TOTAL ASSETS

$63,674,000,000 BILLION – .12/31/2011 (3 months ended)

The aftermath, a $1,610 BILLION ($1,610,000,000 Billion) increase to:

$65,284,000,000 BILLION – 3/31/2012 (3 months ended)
——————————————————————
With the current TOTAL ASSETS being a miserly:

$66,598,000,000 BILLION – 9/30/2013 (3 months ended)
——————————————————————
I’m NOT quite sure how they’ll be able to function!!
======================================
Next, Bob Blaskiewicz tries to claim that since his vehicle uses gas, and a Rolls Royce uses gas, his car is like a Rolls Royce Silver Arrow
——————————————————————
.12/31/2011 (3 months ended) Cash and cash equivalents (Current assets)
——————————————————————
$3 BILLION (3,000,000,000 Billion)
is
33.871514056678336%
of
$8,857,000,000 BILLION
——————————————————————
2/7/2012 – $3 BILLION ($3,000,000,000 fine)
——————————————————————
3/31/2012 (3 months ended) Cash and cash equivalents (Current assets)
——————————————————————
$3 BILLION (3,000,000,000 Billion)
is
33.2667997338656%
of
$9,018,000,000 BILLION
——————————————————————
.12/31/2011 (3 months ended) Total current assets
——————————————————————
$3 BILLION (3,000,000,000 Billion)
is
11.971746677840295%
of
$25,059,000,000 BILLION
——————————————————————
2/7/2012 – $3 BILLION ($3,000,000,000 fine)
——————————————————————
3/31/2012 (3 months ended) Total current assets
——————————————————————
$3 BILLION (3,000,000,000 Billion)
is
11.518525628719523%
of
$26,045,000,000 BILLION
——————————————————————
.12/31/2011 (3 months ended) TOTAL ASSETS
——————————————————————
$3 BILLION (3,000,000,000 Billion)
is
4.711499199045136%
of
$63,674,000,000 BILLION
——————————————————————
2/7/2012 – $3 BILLION ($3,000,000,000 fine)
——————————————————————
3/31/2012 (3 months ended) TOTAL ASSETS
——————————————————————
$3 BILLION (3,000,000,000 Billion)
is
4.5953066601311185%
of
$65,284,000,000 BILLION
——————————————————————
9/30/2013 (3 months ended) current TOTAL ASSETS
——————————————————————
$3 BILLION (3,000,000,000 Billion)
is
4.504639778972342%
of
$66,598,000,000 BILLION
——————————————————————
Gross Domestic Product (GDP)
——————————————————————
67 countries
68th – GSK would rank ($66,598,000,000 BILLION)
of
214
——————————————————————
======================================
EARNINGS PER SHARE
——————————————————————
95.2¢☝9/30/2013 (9 months ended)
31.0¢👇9/30/2013 (3 months ended)
64.2¢☝6/30/2013 (6 months ended)
33.1¢☝6/30/2013 (
3 months ended
31.0¢👇3/31/2013 (3 months ended)
$147.7☝.12/31/2012 (12 months ended)
28.8¢👇.12/31/2012 (3 months ended)
$118.5☝9/30/2012 (9 months ended)
36.2¢👇9/30/2012 (3 months ended)
82.3¢☝6/30/2012 (6 months ended)
40.1¢☝6/30/2012 (
3 months ended)
42.2¢👇3/31/2012 (3 months ended)
$168.4☝.12/31/2011 (12 months ended)
40.6¢👇.12/31/2011 (3 months ended)
$127.8☝9/30/2011 (9 months ended)
43.9¢👇9/30/2011 (3 months ended)
83.9¢☝6/30/2011 (6 months ended)
35.8¢👇6/30/2011 (3 months ended)
48.0¢👇3/31/2011 (3 months ended)
49.8¢☝.12/31/2010 (12 months ended)
(–21.5¢ LOSS)👇.12/31/2010 (3 months ended)
70.4¢☝9/30/2010 (9 months ended)
39.5¢☝9/30/2010 (
3 months ended)
31.2¢☝6/30/2010 (
6 months ended)
(– 9.0¢ LOSS)👇6/30/2010 (3 months ended)
41.2¢👇3/31/2010 (3 months ended)
$170.2☝.12/31/2009 (12 months ended)
52.0¢👇.12/31/2009 (3 months ended)
$118.6 ☝9/30/2009 (9 months ended)
42.6¢👇9/30/2009 (3 months ended)
75.9¢☝6/30/2009 (6 months ended)
44.1¢☝6/30/2009 (
3 months ended)
32.1¢☝3/31/2009 (
3 months ended)
——————————————————————
12 months ended (12/31/2009-12/31/2012)
——————————————————————
$147.7👇.12/31/2012 (12 months ended)
$168.4☝.12/31/2011 (12 months ended)
49.8¢👇.12/31/2010 (12 months ended)
$170.2☝.12/31/2009 (12 months ended)
——————————————————————
9 months ended (9/30/2009-9/30/2013)
——————————————————————
95.2¢👇9/30/2013 (9 months ended)
$118.5👇9/30/2012 (9 months ended)
$127.8☝9/30/2011 (9 months ended)
70.4¢👇9/30/2010 (9 months ended)
$118.6☝9/30/2009 (9 months ended)
——————————————————————
6 months ended (6/30/2009-6/30/2013)
——————————————————————
64.2¢👇6/30/2013 (6 months ended)
82.3¢👇6/30/2012 (6 months ended)
83.9¢☝6/30/2011 (6 months ended)
31.2¢👇6/30/2010 (6 months ended)
75.9¢☝6/30/2009 (6 months ended)
——————————————————————
3 months ended (3/31/2009-9/30/2013)
——————————————————————
31.0¢👇9/30/2013 (3 months ended)
33.1¢☝6/30/2013 (3 months ended)
31.0¢☝3/31/2013 (
3 months ended)
28.8¢👇.12/31/2012 (3 months ended)
36.2¢👇9/30/2012 (3 months ended)
40.1¢👇6/30/2012 (3 months ended)
42.2¢☝3/31/2012 (3 months ended)
40.6¢👇.12/31/2011 (3 months ended)
43.9¢☝9/30/2011 (3 months ended)
35.8¢👇6/30/2011 (3 months ended)
48.0¢☝3/31/2011 (3 months ended)
(– 21.5¢ LOSS)👇.12/31/2010 (3 months ended)
39.5¢☝9/30/2010 – (3 months ended)
(– 9.0¢ LOSS)👇6/30/2010 (3 months ended)
41.2¢👇3/31/2010 (3 months ended)
52.0¢☝.12/31/2009 (3 months ended)
42.6¢👇9/30/2009 (3 months ended)
44.1¢☝6/30/2009 (3 months ended)
32.1¢☝3/31/2009 (
3 months ended)
——————————————————————
Profit attributable to shareholders
——————————————————————
$4,611,000,000 BILLION☝9/30/2013 (9 months ended)
$1,502,000,000 BILLION👇9/30/2013 (3 months ended)
$3,109,000,000 BILLION☝6/30/2013 (6 months ended)
$1,610,000,000 BILLION☝6/30/2013 (
3 months ended)
$1,499,000,000 BILLION👇3/31/2013 (3 months ended)
$7,258,000,000 BILLION☝.12/31/2012 (12 months ended)
$1,410,000,000 BILLION👇.12/31/2012 (3 months ended)
$5,848,000,000 BILLION☝9/30/2012 (9 months ended)
$1,773,000,000 BILLION👇9/30/2012 (3 months ended)
$4,075,000,000 BILLION☝6/30/2012 (6 months ended)
$1,981,000,000 BILLION👇6/30/2012 (3 months ended)
$2,094,000,000 BILLION👇3/31/2012 (3 months ended)
$8,471,000,000 BILLION☝.12/31/2011 (12 months ended)
$2,017,000,000 BILLION👇.12/31/2011 (3 months ended)
$6,454,000,000 BILLION☝9/30/2011 (9 months ended)
$2,191,000,000 BILLION👇9/30/2011 (3 months ended)
$4,263,000,000 BILLION☝6/30/2011 (6 months ended)
$1,824,000,000 BILLION👇6/30/2011 (3 months ended)
$2,439,000,000 BILLION👇3/31/2011 (3 months ended)
$2,532,000,000 BILLION☝.12/31/2010 (12 months ended)
(–$1,046,000,000 BILLION LOSS)👇.12/31/2010 (3 months ended)
$3,578,000,000 BILLION☝9/30/2010 (9 months ended)
$1,993,000,000 BILLION☝9/30/2010 – (
3 months ended)
$1,585,000,000 BILLION☝6/30/2010 (
6 months ended)
(– $505,000,000 million LOSS)👇6/30/2010 (3 months ended)
$2,090,000,000 BILLION👇3/31/2010 (3 months ended)
$8,629,000,000 BILLION☝.12/31/2009 (12 months ended)
$2,622,000,000 BILLION👇.12/31/2009 (3 months ended)
$6,007,000,000 BILLION☝9/30/2009 (9 months ended)
$2,158,000,000 BILLION👇9/30/2009 (3 months ended)
$3,849,000,000 BILLION👇6/30/2009 (6 months ended)
$3,849,000,000 BILLION☝6/30/2009 (3 months ended)
$1,629,000,000 BILLION☝3/31/2009 (
3 months ended)
——————————————————————
12 months ended (12/31/2009-12/31/2012)
——————————————————————
$7,258,000,000 BILLION👇.12/31/2012 (12 months ended)
$8,471,000,000 BILLION☝.12/31/2011 (12 months ended)
$2,532,000,000 BILLION👇.12/31/2010 (12 months ended)
$8,629,000,000 BILLION☝.12/31/2009 (12 months ended)
——————————————————————
9 months ended (9/30/2009-9/30/2013
——————————————————————
$4,611,000,000 BILLION👇9/30/2013 (9 months ended)
$5,848,000,000 BILLION👇9/30/2012 (9 months ended)
$6,454,000,000 BILLION☝9/30/2011 (9 months ended)
$3,578,000,000 BILLION👇9/30/2010 (9 months ended)
$6,007,000,000 BILLION☝9/30/2009 (9 months ended)
——————————————————————
6 months ended (6/30/2009-6/30/2013)
——————————————————————
$3,109,000,000 BILLION👇6/30/2013 (6 months ended)
$4,075,000,000 BILLION👇6/30/2012 (6 months ended)
$4,263,000,000 BILLION☝6/30/2011 (6 months ended)
$1,585,000,000 BILLION👇6/30/2010 (6 months ended)
$3,849,000,000 BILLION☝6/30/2009 (6 months ended)
——————————————————————
3 months ended (3/31/2009-9/30/2013)
——————————————————————
$1,502,000,000 BILLION👇9/30/2013 (3 months ended)
$1,610,000,000 BILLION☝6/30/2013 (3 months ended)
$1,499,000,000 BILLION☝3/31/2013 (
3 months ended)
$1,410,000,000 BILLION👇.12/31/2012 (3 months ended)
$1,773,000,000 BILLION👇9/30/2012 (3 months ended)
$1,981,000,000 BILLION👇6/30/2012 (3 months ended)
$2,094,000,000 BILLION☝3/31/2012 (3 months ended)
$2,017,000,000 BILLION👇.12/31/2011 (3 months ended)
$2,191,000,000 BILLION☝9/30/2011 (3 months ended)
$1,824,000,000 BILLION👇6/30/2011 (3 months ended)
$2,439,000,000 BILLION☝3/31/2011 (3 months ended)
(– $1,046,000,000 BILLION LOSS)👇.12/31/2010 (3 months ended)
$1,993,000,000 BILLION☝9/30/2010 – (3 months ended)
(– $505,000,000 million LOSS)👇6/30/2010 (3 months ended)
$2,090,000,000 BILLION👇3/31/2010 (3 months ended)
$2,622,000,000 BILLION☝.12/31/2009 (3 months ended)
$2,158,000,000 BILLION👇9/30/2009 (3 months ended)
$3,849,000,000 BILLION☝6/30/2009 (3 months ended)
$1,629,000,000 BILLION☝3/31/2009 (
3 months ended)
——————————————————————
Cash and cash equivalents (Current assets)
——————————————————————
$5,268,000,000 BILLION☝9/30/2013 (3 months ended)
$4,318,000,000 BILLION👇6/30/2013 (3 months ended)
$5,825,000,000 BILLION👇3/31/2013 (3 months ended)
$6,820,000,000 BILLION☝.12/31/2012 (3 months ended)
$5,459,000,000 BILLION👇9/30/2012 (3 months ended)
$11,601,000,000 BILLION☝6/30/2012 (3 months ended)
$9,018,000,000 BILLION☝3/31/2012 (
3 months ended)
$8,857,000,000 BILLION☝.12/31/2011 (
3 months ended)
$8,446,000,000 BILLION👇9/30/2011 (3 months ended)
$9,412,000,000 BILLION👇6/30/2011 (3 months ended)
$10,397,000,000 BILLION☝3/31/2011 (3 months ended)
$9,449,000,000 BILLION👇.12/31/2010 (3 months ended)
$9,842,000,000 BILLION👇9/30/2010 – (3 months ended)
$9,861,000,000 BILLION👇6/30/2010 (3 months ended)
$10,585,000,000 BILLION☝3/31/2010 (3 months ended)
$10,357,000,000 BILLION☝.12/31/2009 (
3 months ended)
$10,347,000,000 BILLION☝9/30/2009 (
3 months ended)
$8,821,000,000 BILLION👇6/30/2009 (3 months ended)
$8,896,000,000 BILLION☝3/31/2009 (3 months ended)
——————————————————————
Total current assets
——————————————————————
$21,825,000,000 BILLION☝9/30/2013 (3 months ended)
$20,423,000,000 BILLION👇6/30/2013 (3 months ended)
$21,458,000,000 BILLION👇3/31/2013 (3 months ended)
$22,318,000,000 BILLION☝.12/31/2012 (3 months ended)
$21,724,000,000 BILLION👇9/30/2012 (3 months ended)
$27,105,000,000 BILLION☝6/30/2012 (3 months ended)
$26,045,000,000 BILLION☝3/31/2012 (
3 months ended)
$25,059,000,000 BILLION👇.12/31/2011 (3 months ended)
$25,573,000,000 BILLION👇9/30/2011 (3 months ended)
$26,257,000,000 BILLION👇6/30/2011 (3 months ended)
$26,882,000,000 BILLION☝3/31/2011 (3 months ended)
$25,016,000,000 BILLION👇.12/31/2010 (3 months ended)
$26,533,000,000 BILLION☝9/30/2010 – (3 months ended)
$25,619,000,000 BILLION👇6/30/2010 (3 months ended)
$27,901,000,000 BILLION👇3/31/2010 (3 months ended)
$28,288,000,000 BILLION☝.12/31/2009 (3 months ended)
$27,745,000,000 BILLION☝9/30/2009 (
3 months ended)
$25,161,000,000 BILLION☝6/30/2009 (
3 months ended)
$24,263,000,000 BILLION☝3/31/2009 (
3 months ended)
——————————————————————
TOTAL ASSETS
——————————————————————
$66,598,000,000 BILLION☝9/30/2013 (3 months ended)
$63,930,000,000 BILLION👇6/30/2013 (3 months ended)
$65,196,000,000 BILLION👇3/31/2013 (3 months ended)
$67,604,000,000 BILLION☝.12/31/2012 (3 months ended)
$65,129,000,000 BILLION👇9/30/2012 (3 months ended)
$66,658,000,000 BILLION☝6/30/2012 (3 months ended)
$65,284,000,000 BILLION☝3/31/2012 (
3 months ended)
$63,674,000,000 BILLION👇.12/31/2011 (3 months ended)
$64,559,000,000 BILLION👇9/30/2011 (3 months ended)
$67,745,000,000 BILLION👇6/30/2011 (3 months ended)
$68,125,000,000 BILLION☝3/31/2011 (3 months ended)
$65,601,000,000 BILLION👇.12/31/2010 (3 months ended)
$67,384,000,000 BILLION☝9/30/2010 – (3 months ended)
$64,580,000,000 BILLION👇6/30/2010 (3 months ended)
$67,726,000,000 BILLION👇3/31/2010 (3 months ended)
$69,007,000,000 BILLION☝.12/31/2009 (3 months ended)
$66,315,000,000 BILLION☝9/30/2009 (
3 months ended)
$59,336,000,000 BILLION☝6/30/2009 (
3 months ended)
$56,009,000,000 BILLION☝3/31/2009 (
3 months ended)
======================================

======================================
REFERENCES:
======================================
[1] – 12/2/2013 – Robert J. (don’t call me “Bobby”) “Bob” (I’m NOT a doctor, I just pretend that I’m one on The Other Burzynski Patient Group (TOBPG)) Blaskiewicz Blatherskitewicz’s Burzynski “IS big pharma”::
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/12/02/robert-j-dont-call-me-bobby-bob-im-not-a-doctor-i-just-play-like-im-one-on-the-other-burzynski-patient-group-tobpg-blaskiewicz-blatherskitewicz/
======================================
[2] – 11/26/2013 – United States Department of Justice (DOJ) versus BIG Pharma: BIG Pharma fought the law, and the law won ?:
——————————————————————
https://stanislawrajmundburzynski.wordpress.com/2013/11/26/united-states-department-of-justice-versus-big-pharma-big-pharma-fought-the-law-and-the-law-won/
======================================
2013

——————————————————————

Click to access Q3-2013-US-dollar-translation.pdf

——————————————————————
2013

——————————————————————

Click to access Q2-2013-US-dollar-translation.pdf

——————————————————————
2013

——————————————————————

Click to access Q1-2013-US-dollar-translation.pdf

======================================
2012

——————————————————————

Click to access Q4-2012-US-dollar-translation.pdf

——————————————————————
2012

——————————————————————

Click to access Q3-2012-US-dollar-translation.pdf

——————————————————————
2012

——————————————————————

Click to access Q2-2012-US-dollar-translation.pdf

——————————————————————
2012

——————————————————————

Click to access Q1-2012-US-dollar-translation.pdf

======================================
2011

——————————————————————

Click to access Q4-2011-US-dollar-translation.pdf

——————————————————————
2011

——————————————————————

Click to access Q3-2011-US-dollar-translation.pdf

——————————————————————
2011

——————————————————————

Click to access Q2-2011-US-dollar-translation.pdf

——————————————————————
2011

——————————————————————

Click to access Q1-2011-US-dollar-translation.pdf

======================================
2010

——————————————————————

Click to access Q4-2010-US-dollar-translation.pdf

——————————————————————
2010

——————————————————————

Click to access Q3-2010-US-dollar-translation.pdf

——————————————————————
2010

——————————————————————

Click to access Q2-2010-US-dollar-translation.pdf

——————————————————————
2010

——————————————————————

Click to access Q1-2010-US-dollar-translation.pdf

======================================
2009

——————————————————————

Click to access Q4-2009-US-dollar-translation.pdf

——————————————————————
2009

——————————————————————

Click to access Q3-2009-US-dollar-translation.pdf

——————————————————————
2009

——————————————————————

Click to access Q2-2009-US-dollar-translation.pdf

——————————————————————
2009

——————————————————————

Click to access Q1-2009-US-dollar-translation.pdf

======================================

Advertisement
Posted in bias, biased, BIG Pharma, Bob Blaskiewicz (Robert J. Blaskiewicz @rjblaskiewicz), critique, critiques, critiqued, critiquing, Stanislaw Rajmund Burzynski, The Skeptics | Tagged "(GSK)", "12 months ended", "3 months ended", "5th-grade", "6 months ended", "9 months ended", "Big pharmaceutical company", "BILLION Pharma", "Blatherskitewicz’s", "blogger at skepticalhumanities.com", "Bob ‘n Weave Blaskiewicz", "Bob Blaskiewicz Faux Skeptic Exposed!", "Bobby Blatherskite", "Bobby Blatherskitewicz", "Bobby’s", "Burzynski Skeptics", "Cash and cash equivalents (Current assets)", "Center for Inquiry", "Committee for Skeptical Inquiry", "Didymus Judas Thomas’ Hipocritical Oath Blog", "drug companies", "EARNINGS PER SHARE", "Eau Claire", "end-run", "fifth-grade", "Fifth-grader”, "Gabroni’s", "GlaxoSmithKline LLC", "Gross Domestic Product (GDP)", "gsk.com/", "http://gsk.com/""http://www.gsk.com/", "http://gsk.com/content/", "http://gsk.com/content/dam/", "http://gsk.com/content/dam/gsk/", "http://gsk.com/content/dam/gsk/globals/", "http://gsk.com/content/dam/gsk/globals/documents/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q1-2009-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q2-2009-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q3-2009-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q4-2009-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q1-2010-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q2-2010-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q3-2010-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q4-2010-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q2-2011-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q3-2011-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q4-2011-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q1-2012-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q2-2012-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q3-2012-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q4-2012-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/Q1-2013-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/Q2-2013-US-dollar-translation.pdf", "http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/Q3-2013-US-dollar-translation.pdf", "https://stanislawrajmundburzynski.wordpress.com/2013/12/02/ouchie/", "https://stanislawrajmundburzynski.wordpress.com/2013/12/02/robert-j-dont-call-me-bobby-bob-im-not-a-doctor-i-just-play-like-im-one-on-the-other-burzynski-patient-group-tobpg-blaskiewicz-blatherskitewi, "http://www.gsk.com/content/", "http://www.gsk.com/content/dam/", "http://www.gsk.com/content/dam/gsk/", "http://www.gsk.com/content/dam/gsk/globals/", "http://www.gsk.com/content/dam/gsk/globals/documents/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q1-2009-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q2-2009-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q3-2009-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2009/Q4-2009-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q1-2010-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q3-2010-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q4-2010-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q2-2011-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q3-2011-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q4-2011-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q1-2012-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q2-2012-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q3-2012-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2012/Q4-2012-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/Q1-2013-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/Q2-2013-US-dollar-translation.pdf", "http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2013/Q3-2013-US-dollar-translation.pdf", "intelligent-design", "JREF Swift Blog contributor", "large poophole“, "medical-grade cannabis", "months ended", "nine months ended", "Northeast Conference on Science and Skepticism", "OUCHIE !!! https://stanislawrajmundburzynski.wordpress.com/2013/12/02/ouchie/", "OUCHIE", "Pavlov’s dog”, "piss-poor", "plausible story”, "Pol Pot", "Profit attributable to shareholders", "Robert J. (don’t call me Bobby) Bob (I’m NOT a doctor, "Robert J. Blaskiewicz", "Rolls Royce Silver Arrow", "Rolls Royce", "six months ended", "Skeptical Inquirer", "Skeptical Inquiry", "Skepticality podcast", "smarter than a 5th grader", "St. Louis, "talking-head", "TAM 2013", "The Amazing Meeting", "The Virtual Skeptics", "theamazingmeeting.com", "three months ended", "TOTAL ASSETS", "Total current assets", "twelve months ended", "United States Department of Justice (DOJ) versus BIG Pharma: BIG Pharma fought the law, "University of Wisconsin Eau Claire, "University of Wisconsin", "Visiting Assistant Professor of Writing at the University of Wisconsin-Eau Claire", "web columnist", "Why we fight for patients", "word-salad", "www.gsk.com/", "www.theamazingmeeting.com", #TAM2013, @PrismPodcast, @rjblaskiewicz, able, actions, actual, adding, affect, after, aftermath, agree, akin, and the law won ?", announcement, around, as Stupid Does”, asked, attempt, attempting, attributable, available, “Big Pharma”, “Black Monday”, “Conspiracy Guy”, “Down, “full of", “He IS big pharma”, “He uses the same legal loopholes available to drug companies", “legal loopholes”, “Sexual Predator”, “Stupid is, back-up", based, basically, because, been, before, being, belief, believes, bias, Biased, BIG, Blatherskitewicz, Bob, Bob Blaskiewicz, Bobby, Booby, brilliance, brillnuance, candy, car, Cash, Certainly, Charmin, child, CHILDREN, choice, cite, Claim, clear, confused, contrast, correct, countries, creepers, Current. assets, day, depositing, device, digress, dollar, dollars, during, elicit, end, ended, enough, equivalents, even, events, examples, excreted, Facebook, fall, feels, fine, fined, follow, followers, forego, form, founded, fruit, function, gas, gem, help, himself, hopes, http://anp4all.com, http://blog.rbutr.com/, http://centerforinquiry.net/speakers/blaskiewicz_bob, http://gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q1-2011-US-dollar-translation", http://lanyrd.com/2013/tam/sckkdy/, http://necss.org/speakers/bob-blaskiewicz/, http://rbutr.com/, http://skepticalhumanities.com/, https://stanislawrajmundburzynski.wordpress.com/2013/11/26/united-states-department-of-justice-versus-big-pharma-big-pharma-fought-the-law-and-the-law-won/, http://theamazingmeeting.com, http://thehoustoncancerquack.com/, http://uwec.edu/Staff/blaskir/, http://virtualskeptics.com/, http://www.centerforinquiry.net/speakers/blaskiewicz_bob, http://www.csicop.org/author/rblaskiewicz, http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2010/Q2-2010-US-dollar-translation.pdf", http://www.gsk.com/content/dam/gsk/globals/documents/pdf/Investors/quarterly-results/2011/Q1-2011-US-dollar-translation", http://www.skepticalhumanities.com, http://www.theamazingmeeting.com, http://www.uwec.edu/Staff/blaskir/, https://mobile.twitter.com/rjblaskiewicz, I just pretend that I’m one on The Other Burzynski Patient Group (TOBPG)) Blaskiewicz Blatherskitewicz’s Burzynski IS big pharma”, ignoring, increase, instead, instructed, intelligent, into, Jeepers, juice, just, largest, last, law, least, legal, loopholes, LOSS, means, menagerie, menutgerie, mightily, million, MILLION. RISE, MisDisInform, miserly, Missouri", month, months, must, name, never, news, Next, now, nut, obviously, occurred, opposition, over, parent, Peepers, perhaps, phallicy, pimps, poltroon, Prevaricator, Prize, profit, Pulitzer, pull, puts, quaint, quite, r-but-r, rank, rbutr, readers, regular, review, rid, rjblatherskiewicz, roll, salute, same, see, select, selected, series, sessions, shape, shareholders, shiny, since, sits, Skeptical Humanities, skepticalhumanities, slap, smart, smarter, somehow, somewhere, sorry, stick, stranger, strangers, stupid, style, suckered, supply, supposedly, sure, surely, surprise, syllabus, symbolism, talk, that, The Skeptics, theamazingmeeting, theory, through, toilet, told, Tolstory, translates, tree, tries, trying, Twitter, type, unable, use, uses, valid, vehicle, virtualskeptics, warnings, way, which, Wisconsin" http://uwec.edu/Staff/blaskir/, world, would, wrist, your | Leave a reply

Search

Recent posts

  • Pete Cohen films Pat and Steve Clarkson January 15, 2014
  • Pete Cohen talks to Steve and Mary Jo Siegel January 14, 2014
  • Pete Cohen talks with Doug Olson January 10, 2014
  • Pete Cohen talks with Burzynski Patient January 8, 2014
  • Dr. Li-Chuan Chin, PhD, National Cancer Institute Scientist (1991-1997) talks about Dr. Burzynski and Antineoplastons January 6, 2014

Archives

Categories

Meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com
Blog at WordPress.com.
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
  • Follow Following
    • Didymus Judas Thomas' Hipocritical Oath Blog
    • Already have a WordPress.com account? Log in now.
    • Didymus Judas Thomas' Hipocritical Oath Blog
    • Customize
    • Follow Following
    • Sign up
    • Log in
    • Report this content
    • View site in Reader
    • Manage subscriptions
    • Collapse this bar